Read + Share
Tuninetti V, Virano E, Salutari V, Ricotti A, et al. Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a
nominal use program in Italy: The MITO 44 study. Eur J Cancer 2024;203:114039.
PMID: 38598922
|
 |
|
Tuninetti V, Virano E, Salutari V, Ricotti A, et al. Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a
nominal use program in Italy: The MITO 44 study. Eur J Cancer 2024;203:114039.
PMID: 38598922
|
|
|
|